Skip to main content
TDAC logo

TDAC · Translational Development Acquisition Corp.

$10.88 +0.03 (+0.28%)
Market Cap
$237.59M
Shares
21.91M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Net Income
$6.36M +9059.7%
FY2025 Net Income FY2023–FY2025
Operating Cash Flow
-$608.39K +28.5%
FY2025 Operating Cash Flow FY2023–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023
$878.29K $944.54K $196.36K
-$878.29K -$944.54K -$196.36K -$485.55K
$7.09M $7.31M $125.35K
$0
$6.21M $6.36M -$71.01K -$485.55K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
EV/EBIT
P/E (TTM)
Shell Companies median 26.87×
Key facts CIK 1926599 CUSIP G9008W105 13F (30d) 3 filings 3 filers Visit website Investor relations